1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Controlled Substance Market

4. Market Overview

    4.1. Introduction

        4.1.1. Class Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Controlled Substance Market Analysis and Forecasts, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

    5.1. Pipeline Analysis

    5.2. Key Merger & Acquisition

    5.3. Regulatory Scenario

6. Global Controlled Substance Market Analysis and Forecasts, by Drug, 2017-2027 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Drug, 2017–2027

        6.3.1. Opioids

            6.3.1.1. Codeine

            6.3.1.2. Morphine

            6.3.1.3. Fentanyl

            6.3.1.4. Hydrocodone

            6.3.1.5. Tramadol

            6.3.1.6. Oxycodone

            6.3.1.7. Others

        6.3.2. Stimulants

            6.3.2.1. Amphetamine

            6.3.2.2. Methylphenidate

            6.3.2.3. Dextroamphetamine

            6.3.2.4. Methamphetamine

            6.3.2.5. Modafinil

            6.3.2.6. Others

        6.3.3. Depressants

            6.3.3.1. Barbiturates

            6.3.3.2. Benzodiazepines

        6.3.4. Cannabinoids

    6.4.  Market Attractiveness, by Drug 

7. Global Controlled Substance Market Analysis and Forecasts, by Application, 2017-2027 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2027

        7.3.1. ADHD

        7.3.2. Pain Management

        7.3.3. Depression

        7.3.4. Sleep Disorder

        7.3.5. Cough Suppression

        7.3.6. Anxiety

        7.3.7. Seizure

        7.3.8. Others

    7.4.  Market Attractiveness, by Application 

8. Global Controlled Substance Market Analysis and Forecasts, by Distribution Channel

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Distribution Channel, 2017–2027

        8.3.1. Hospital Pharmacies

        8.3.2. Retail Pharmacies

        8.3.3. Online Pharmacies

    8.4. Market Attractiveness, by Application

9. Global Controlled Substance Market Analysis and Forecasts, by Region, 2017-2027

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Market Attractiveness, by Region

10. North America Controlled Substance Market Analysis and Forecast, 2017-2027

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Drug, 2017–2027

        10.2.1. Opioids

            10.2.1.1. Codeine

            10.2.1.2. Morphine

            10.2.1.3. Fentanyl

            10.2.1.4. Hydrocodone

            10.2.1.5. Tramadol

            10.2.1.6. Oxycodone

            10.2.1.7. Others

        10.2.2. Stimulants

            10.2.2.1. Amphetamine

            10.2.2.2. Methylphenidate

            10.2.2.3. Dextroamphetamine

            10.2.2.4. Methamphetamine

            10.2.2.5. Modafinil

            10.2.2.6. Others

        10.2.3. Depressants

            10.2.3.1. Barbiturates

            10.2.3.2. Benzodiazepines

        10.2.4. Cannabinoids

    10.3. Market Value Forecast, by Application, 2017-2027

        10.3.1. ADHD

        10.3.2. Pain Management

        10.3.3. Depression

        10.3.4. Sleep Disorder

        10.3.5. Cough Suppression

        10.3.6. Anxiety

        10.3.7. Seizure

        10.3.8. Others

    10.4. Market Value Forecast, by Distribution Channel, 2017-2027

        10.4.1. Hospital Pharmacies

        10.4.2. Retail Pharmacies

        10.4.3. Online Pharmacies

    10.5. Market Value Forecast, by Country, 2017-2027 

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis 

        10.6.1. By Drug 

        10.6.2. By Application 

        10.6.3. By Distribution Channel

        10.6.4. By Country

11. Europe Controlled Substance Market Analysis and Forecast, 2017-2027

    11.1. Introduction

        11.1.1. Key Finding

    11.2. Market Value Forecast, by Drug, 2017-2027

        11.2.1. Opioids

            11.2.1.1. Codeine

            11.2.1.2. Morphine

            11.2.1.3. Fentanyl

            11.2.1.4. Hydrocodone

            11.2.1.5. Tramadol

            11.2.1.6. Oxycodone

            11.2.1.7. Others

        11.2.2. Stimulants 

            11.2.2.1. Amphetamine

            11.2.2.2. Methylphenidate

            11.2.2.3. Dextroamphetamine

            11.2.2.4. Methamphetamine

            11.2.2.5. Modafinil

            11.2.2.6. Others

        11.2.3. Depressants

            11.2.3.1. Barbiturates

            11.2.3.2. Benzodiazepines

        11.2.4. Cannabinoids

    11.3. Market Value Forecast, by Application, 2017-2027

        11.3.1. ADHD

        11.3.2. Pain Management

        11.3.3. Depression

        11.3.4. Sleep Disorder

        11.3.5. Cough Suppression

        11.3.6. Anxiety

        11.3.7. Seizure

        11.3.8. Others

    11.4. Market Value Forecast, by Distribution Channel, 2017-2027

        11.4.1. Hospital Pharmacies

        11.4.2. Retail Pharmacies

        11.4.3. Online Pharmacies

    11.5. Market Value Forecast, by Country/Sub-region, 2017-2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis 

        11.6.1. By Drug 

        11.6.2. By Application 

        11.6.3. By Distribution Channel

        11.6.4. By Country/Sub-region

12. Asia Pacific Controlled Substance Market Analysis and Forecast, 2017-2027

    12.1. Introduction

        12.1.1. Key Finding

    12.2. Market Value Forecast, by Drug, 2017-2027

        12.2.1. Opioids

            12.2.1.1. Codeine

            12.2.1.2. Morphine

            12.2.1.3. Fentanyl

            12.2.1.4. Hydrocodone

            12.2.1.5. Tramadol

            12.2.1.6. Oxycodone

            12.2.1.7. Others

        12.2.2. Stimulants 

            12.2.2.1. Amphetamine

            12.2.2.2. Methylphenidate

            12.2.2.3. Dextroamphetamine

            12.2.2.4. Methamphetamine

            12.2.2.5. Modafinil

            12.2.2.6. Others

        12.2.3. Depressants

            12.2.3.1. Barbiturates

            12.2.3.2. Benzodiazepines

        12.2.4. Cannabinoids 

    12.3. Market Value Forecast, by Application, 2017-2027

        12.3.1. ADHD

        12.3.2. Pain Management

        12.3.3. Depression

        12.3.4. Sleep Disorder

        12.3.5. Cough Suppression

        12.3.6. Anxiety

        12.3.7. Seizure

        12.3.8. Others

    12.4. Market Value Forecast, by Distribution Channel, 2017-2027

        12.4.1. Hospital Pharmacies

        12.4.2. Retail Pharmacies

        12.4.3. Online Pharmacies

    12.5. Market Value Forecast, by Country/Sub-region, 2017-2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis 

        12.6.1. By Drug 

        12.6.2. By Application 

        12.6.3. By Distribution Channel

        12.6.4. By Country/Sub-region

13. Latin America Controlled Substance Market Analysis and Forecast, 2017-2027

    13.1. Introduction

        13.1.1. Key Finding

    13.2. Market Value Forecast, by Drug, 2017-2027

        13.2.1. Opioids

            13.2.1.1. Codeine

            13.2.1.2. Morphine

            13.2.1.3. Fentanyl

            13.2.1.4. Hydrocodone

            13.2.1.5. Tramadol

            13.2.1.6. Oxycodone

            13.2.1.7. Others

        13.2.2. Stimulants 

            13.2.2.1. Amphetamine

            13.2.2.2. Methylphenidate

            13.2.2.3. Dextroamphetamine

            13.2.2.4. Methamphetamine

            13.2.2.5. Modafinil

            13.2.2.6. Others

        13.2.3. Depressants

            13.2.3.1. Barbiturates

            13.2.3.2. Benzodiazepines

        13.2.4. Cannabinoids

    13.3. Market Value Forecast, by Application, 2017-2027

        13.3.1. ADHD

        13.3.2. Pain Management

        13.3.3. Depression

        13.3.4. Sleep Disorder

        13.3.5. Cough Suppression

        13.3.6. Anxiety

        13.3.7. Seizure

        13.3.8. Others

    13.4. Market Value Forecast, by Distribution Channel, 2017-2027

        13.4.1. Hospital Pharmacies

        13.4.2. Retail Pharmacies

        13.4.3. Online Pharmacies

    13.5. Market Value Forecast by Country/Sub-region, 2017-2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis 

        13.6.1. By Drug 

        13.6.2. By Application 

        13.6.3. By Distribution Channel

        13.6.4. By Country/Sub-region

14. Middle East & Africa Controlled Substance Market Analysis and Forecast, 2017-2027

    14.1. Introduction

        14.1.1. Key Finding

    14.2. Market Value Forecast, by Drug, 2017-2027

        14.2.1. Opioids

            14.2.1.1. Codeine

            14.2.1.2. Morphine

            14.2.1.3. Fentanyl

            14.2.1.4. Hydrocodone

            14.2.1.5. Tramadol

            14.2.1.6. Oxycodone

            14.2.1.7. Others

        14.2.2. Stimulants 

            14.2.2.1. Amphetamine

            14.2.2.2. Methylphenidate

            14.2.2.3. Dextroamphetamine

            14.2.2.4. Methamphetamine

            14.2.2.5. Modafinil

            14.2.2.6. Others

        14.2.3. Depressants

            14.2.3.1. Barbiturates

            14.2.3.2. Benzodiazepines

        14.2.4. Cannabinoids 

    14.3. Market Value Forecast, by Application, 2017-2027

        14.3.1. ADHD

        14.3.2. Pain Management

        14.3.3. Depression

        14.3.4. Sleep Disorder

        14.3.5. Cough Suppression

        14.3.6. Anxiety

        14.3.7. Seizure

        14.3.8. Others

    14.4. Market Value Forecast, by Distribution Channel, 2017-2027

        14.4.1. Hospital Pharmacies

        14.4.2. Retail Pharmacies

        14.4.3. Online Pharmacies

    14.5. Market Value Forecast, by Country/Sub-region, 2017-2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis 

        14.6.1. By Drug 

        14.6.2. By Application 

        14.6.3. By Distribution Channel

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Market Position/Ranking Analysis by Company (2018)

    15.3. Company Profiles

        15.3.1. F. Hoffmann-La Roche AG

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Company Financials

            15.3.1.3. Growth Strategies

            15.3.1.4. SWOT Analysis

        15.3.2. AbbVie, Inc.

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Company Financials

            15.3.2.3. Growth Strategies

            15.3.2.4. SWOT Analysis

        15.3.3. Mallinckrodt plc

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Company Financials

            15.3.3.3. Growth Strategies

            15.3.3.4. SWOT Analysis

        15.3.4. Pfizer, Inc.

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Company Financials

            15.3.4.3. Growth Strategies

            15.3.4.4. SWOT Analysis

        15.3.5. Sun Pharmaceutical Ltd.

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Company Financials

            15.3.5.3. Growth Strategies

            15.3.5.4. SWOT Analysis

        15.3.6. Ampac Fine Chemicals

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Company Financials

            15.3.6.3. Growth Strategies

            15.3.6.4. SWOT Analysis

        15.3.7. GW Pharmaceuticals plc

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Company Financials

            15.3.7.3. Growth Strategies

            15.3.7.4. SWOT Analysis

        15.3.8. Merck & Co., Inc.

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Company Financials

            15.3.8.3. Growth Strategies

            16.3.8.4. SWOT Analysis

List of Tables

Table 01: Global Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 02: Global Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017–2027

Table 03: Global Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017–2027

Table 04: Global Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017–2027

Table 05: Global Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 06: Global Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 07: Global Controlled Substance Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 08: North America Controlled Substance Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09: North America Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 10: North America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017–2027

Table 11: North America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017–2027

Table 12: North America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017–2027

Table 13: North America Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 14: North America Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 15: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 17: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017–2027

Table 18: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017–2027

Table 19: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017–2027

Table 20: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 21: Europe Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 22: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 23: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 24: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017–2027

Table 25: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017–2027

Table 26: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017–2027

Table 27: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 28: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 29: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 30: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 31: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017–2027

Table 32: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017–2027

Table 33: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017–2027

Table 34: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 35: Latin America Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 36: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 37: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 38: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Opioids), 2017–2027

Table 39: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Stimulants), 2017–2027

Table 40: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Drug (Depressants), 2017–2027

Table 41: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 42: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

List of Figures

Figure 01: Global Controlled Substance Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 02: Market Opportunity Map, by Drug Type, 2018

Figure 03: Global Controlled Substance Market Value (US$ Mn) Forecast, 2017–2027

Figure 04: Global Controlled Substance Market Value Share, by Drug (2018)

Figure 05: Global Controlled Substance Market Value Share, by Application (2018)

Figure 06: Global Controlled Substance Market Value Share, by Distribution Channels (2018)

Figure 07: Global Controlled Substance Market Value Share, by Region (2018)

Figure 08: Global Controlled Substance Market Value Share Analysis, by Drug, 2018 and 2027

Figure 09: Global Controlled Substance Market Revenue (US$ Mn) by Opioids, 2017-2027

Figure 10: Global Controlled Substance Market Revenue (US$ Mn) by Stimulants, 2017-2027

Figure 11: Global Controlled Substance Market Revenue (US$ Mn) by Depressants, 2017-2027

Figure 12: Global Controlled Substance Market Revenue (US$ Mn) by Cannabinoids, 2017-2027

Figure 13: Global Controlled Substance Market Attractiveness Analysis, by Drug, 2019–2027

Figure 14: Global Controlled Substance Market Value Share Analysis, by Application, 2018 and 2027

Figure 15: Global Controlled Substance Market Value (US$ Mn), by ADHD, 2017–2027

Figure 16: Global Controlled Substance Market Value (US$ Mn), by Pain Management, 2017–2027

Figure 17: Global Controlled Substance Market Value (US$ Mn), by Depression, 2017–2027

Figure 18: Global Controlled Substance Market Value (US$ Mn), by Sleep Disorder, 2017–2027

Figure 19: Global Controlled Substance Market Value (US$ Mn), by Cough Suppression, 2017–2027

Figure 20: Global Controlled Substance Market Value (US$ Mn), by Anxiety, 2017–2027

Figure 21: Global Controlled Substance Market Value (US$ Mn), by Seizure, 2017–2027

Figure 22: Global Controlled Substance Market Value (US$ Mn), by Others, 2017–2027

Figure 23: Global Controlled Substance Market Attractiveness, by Application, 2019–2027

Figure 24: Global Controlled Substance Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 25: Global Controlled Substance Market Revenue (US$ Mn) by Hospital Pharmacies, 2017-2027

Figure 26: Global Controlled Substance Market Revenue (US$ Mn) Retail Pharmacies, 2017-2027

Figure 27: Global Controlled Substance Market Revenue (US$ Mn) Online Pharmacies, 2017-2027

Figure 28: Global Controlled Substance Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 29: Global Controlled Substance Market Value Share Analysis, by Region, 2018 and 2027

Figure 30: Global Controlled Substance Market Attractiveness Analysis, by Region, 2019–2027

Figure 31: North America Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 32: North America Controlled Substance Market Value Share, by Country, 2018 and 2027

Figure 33: North America Controlled Substance Market Attractiveness, by Country, 2019–2027

Figure 34: North America Controlled Substance Market Value Share, by Drug, 2018 and 2027

Figure 35: North America Controlled Substance Market Attractiveness, by Drug, 2019–2027

Figure 36: North America Controlled Substance Market Value Share, by Application, 2018 and 2027

Figure 37: North America Controlled Substance Market Attractiveness, by Application, 2019–2027

Figure 38: North America Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027

Figure 39: North America Controlled Substance Market Attractiveness, by Distribution Channel, 2019–2027

Figure 40: Europe Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 41: Europe Controlled Substance Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 42: Europe Controlled Substance Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 43: Europe Controlled Substance Market Value Share, by Drug, 2018 and 2027

Figure 44: Europe Controlled Substance Market Attractiveness, by Drug, 2019–2027

Figure 45: Europe Controlled Substance Market Value Share, by Application, 2018 and 2027

Figure 46: Europe Controlled Substance Market Attractiveness, by Application, 2019–2027

Figure 47: Europe Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027

Figure 48: Europe Controlled Substance Market Attractiveness, by Distribution Channel, 2019–2027

Figure 49: Asia Pacific Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 50: Asia Pacific Controlled Substance Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 51: Asia Pacific Controlled Substance Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 52: Asia Pacific Controlled Substance Market Value Share, by Drug, 2018 and 2027

Figure 53: Asia Pacific Controlled Substance Market Attractiveness, by Drug, 2019–2027

Figure 54: Asia Pacific Controlled Substance Market Value Share, by Application, 2018 and 2027

Figure 55: Asia Pacific Controlled Substance Market Attractiveness, by Application, 2019–2027

Figure 56: Asia Pacific Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027

Figure 57: Asia Pacific Controlled Substance Market Attractiveness, by Distribution Channel, 2019–2027

Figure 58: Latin America Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 59: Latin America Controlled Substance Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 60: Latin America Controlled Substance Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 61: Latin America Controlled Substance Market Value Share, by Drug, 2018 and 2027

Figure 62: Latin America Controlled Substance Market Attractiveness, by Drug, 2019–2027

Figure 63: Latin America Controlled Substance Market Value Share, by Application, 2018 and 2027

Figure 64: Latin America Controlled Substance Market Attractiveness, by Application, 2019–2027

Figure 65: Latin America Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027

Figure 66: Latin America Controlled Substance Market Attractiveness, by Distribution Channel, 2019–2027

Figure 67: Middle East & Africa Controlled Substance Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 68: Middle East & Africa Controlled Substance Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 69: Middle East & Africa Controlled Substance Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 70: Middle East & Africa Controlled Substance Market Value Share, by Drug, 2018 and 2027

Figure 71: Middle East & Africa Controlled Substance Market Attractiveness, by Drug, 2019–2027

Figure 72: Middle East & Africa Controlled Substance Market Value Share, by Application, 2018 and 2027

Figure 73: Middle East & Africa Controlled Substance Market Attractiveness, by Application, 2019–2027

Figure 74: Middle East & Africa Controlled Substance Market Value Share, by Distribution Channel, 2018 and 2027

Figure 75: Middle East & Africa Controlled Substance Market Attractiveness, by Distribution Channel, 2019–2027

Figure 76: Market Position/Ranking Analysis, 2018, by Tier and Size of the Company

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Controlled Substances Market

Buy Now